Risk of birth defects associated with antiretroviral exposure during pregnancy

被引：1
|
作者：
Beckerman, K
Covington, D
Watts, H
Tilson, H
Chavers, S
Sacks, S
机构：
[1] NYU, Sch Med, Dept Ob Gyn, New York, NY USA
[2] PharmaRes Corp, Wilmington, NC USA
[3] NICHHD, Pediat Adolescent Maternal AIDS Branch, Rockville, MD USA
[4] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA
[5] GlaxoSmithKline, Epidemiol, Res Triangle Pk, NC USA
[6] F Hoffmann La Roche & Co Ltd, Epidemiol, Nutley, NJ USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2003年 / 189卷 / 06期
关键词：
D O I：
10.1016/j.ajog.2003.10.012
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
13
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [21] Folic acid antagonists during pregnancy and the risk of birth defects
    Hernández-Díaz, S
    Werler, MM
    Walker, AM
    Mitchell, AA
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22): : 1608 - 1614
  • [22] Use of Fluconazole during Pregnancy and the Risk of Major Birth Defects
    Molgaard-Nielsen, Ditte
    Pasternak, Bjorn
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 15 - 15
  • [23] Oral Fluconazole during Pregnancy and Risk of Birth Defects REPLY
    Molgaard-Nielsen, Ditte
    Pasternak, Bjorn
    Hviid, Anders
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21): : 2061 - 2062
  • [24] Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects
    Molgaard-Nielsen, Ditte
    Pasternak, Bjoern
    Hviid, Anders
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (09): : 830 - 839
  • [25] Sumatriptan and naratriptan exposure during pregnancy and risk of birth defects. What have we learned?
    Cunnington, MC
    Ephross, S
    HEADACHE, 2005, 45 (06): : 805 - 805
  • [26] Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital
    Bera, Ebrahim
    McCausland, Katrin
    Nonkwelo, Roxaan
    Mgudlwa, Batembu
    Chacko, Saji
    Majeke, Busiwe
    AIDS, 2010, 24 (02) : 283 - 289
  • [27] Antibacterial Medication Use During Pregnancy and Risk of Birth Defects National Birth Defects Prevention Study
    Crider, Krista S.
    Cleves, Mario A.
    Reefhuis, Jennita
    Berry, Robert J.
    Hobbs, Charlotte A.
    Hu, Dale J.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (11): : 978 - 985
  • [28] Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa
    Mehta, Ushma C.
    van Schalkwyk, Cari
    Naidoo, Prineetha
    Ramkisson, Arthi
    Mhlongo, Otty
    Maharaj, Niren R.
    Naidoo, Niree
    Fieggen, Karen
    Urban, Michael F.
    Krog, Shaun
    Welte, Alex
    Dheda, Mukesh
    Pillay, Yogan
    Moran, Neil F.
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2019, 20 (01)
  • [29] Maternal risk exposure during pregnancy and infant birth weight
    Slemming, Wiedaad
    Bello, Braimoh
    Saloojee, Haroon
    Richter, Linda
    EARLY HUMAN DEVELOPMENT, 2016, 99 : 31 - 36
  • [30] Exposure to herbal products during pregnancy and the risk of preterm birth
    Moussally, K.
    Oraichi, D.
    Berard, A.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2008, 82 (05) : 366 - 366
12345